Posts

Showing posts with the label Brand : Pomyelo Ingredients : Pomalidomide

Pomyelo 4mg capsules | Pomalidomide | MHP

Image
POMYELO 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 4mg and it belongs to anti-neoplastic drugs Pomyelo 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 4mg c ombination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 4mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 4mg capsules is used by combining with dexamethasone. Pomyelo 4mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo has three primary pharmacological ...

Pomyelo 2mg capsules | Pomalidomide | MHP

Image
POMYELO 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 2mg and it belongs to anti-neoplastic drugs Pomyelo 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 2mg capsules is used by combining with dexamethasone. Pomyelo 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 2mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo has three primary pharmacological activities...

Pomyelo 4mg capsules | Pomalidomide | MHP

Image
POMYELO 4MG POMYELO 4MG DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 4mg and it belongs to anti-neoplastic drugs Pomyelo 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 4mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 4mg is used by combining with dexamethasone. Pomyelo 4mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo 4mg capsules has three primary pharmacological activities against can...